Background High alpha-fetoprotein (AFP) expressions (> 400 ng/mL) are associated with
poor oncological characteristics for hepatocellular carcinoma (HCC). However, prognosis …

Introduction Although preoperative α-fetoprotein (AFP) has been recognized as an important
tumor marker among patients with hepatocellular carcinoma (HCC), the predictive value of …

Background There is currently no established model for predicting the recurrence of
hepatocellular carcinoma (HCC) in patients with negative alpha‐fetoprotein (AFP) after …

Abstract Background and Objective According to the Barcelona Clinic Liver Cancer (BCLC)
algorithm, tumor burden and liver function, but not tumor biology, are the key factors in …

Background: Although many studies have confirmed the prognostic value of preoperative
alpha-fetoprotein (AFP) in patients with hepatocellular carcinoma (HCC), no one study has …

Simple Summary Hepatocellular carcinoma (HCC) tumor burden score (TBS) and α-
fetoprotein (AFP) have been considered important predictors of outcomes among patients …

AIM To investigate whether the change in pre-/post-operation serum alpha-fetoprotein (AFP)
levels is a predictive factor for hepatocellular carcinoma (HCC) outcomes. METHODS We …

UICC staging) and tumor size. Although this study is retrospective, it is of interest both by the
issue raised which is still contradictory and by the large size of the cohort studied by the …

Introduction Alpha‐fetoprotein (AFP) has a valuable role in postoperative surveillance for
hepatocellular carcinoma (HCC) recurrence. The utility of pretreatment or baseline AFP …

Simple Summary The tumor burden score (TBS) is calculated using the Pythagorean
theorem based on the largest tumor size and tumor number (α2+ β2= γ2, where α is the …